SIM
AVTX icon

Spark Investment Management’s Avalo Therapeutics AVTX Stock Holding History

Spark Investment Management’s Portfolio AVTX Stock Details AVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4
Closed -$28K – 54
2020
Q3 		$28K Hold
4
– – 0.04% 47
2020
Q2 		$32K Hold
4
– – 0.12% 68
2020
Q1 		$31K Sell
4
-5
-56% -$52.9K 0.02% 332
2019
Q4 		$140K Sell
9
-14
-61% -$148K 0.02% 486
2019
Q3 		$216K Sell
23
-8
-26% -$89.3K 0.03% 328
2019
Q2 		$482K Buy
31
+2
+7% +$30.3K 0.03% 375
2019
Q1 		$484K Buy
29
+11
+61% +$165K 0.02% 410
2018
Q4 		$167K Sell
18
-5
-22% -$55.7K 0.01% 519
2018
Q3 		$302K Hold
23
– – 0.02% 515
2018
Q2 		$288K Buy
+23
New +$274K 0.02% 509

Other funds holding AVTX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return